Everlywell

Overview

Everlywell is the mass-market DTC at-home test brand, founded in 2015 in Austin, TX. Unlike Function Health, Lifeforce, or InsideTracker — which package comprehensive longevity panels into single subscriptions — Everlywell sells 30+ discrete single-purpose test kits ($49–$299 each) covering STI screening, food sensitivity, thyroid, hormones, fertility, men’s/women’s health, vitamins, and several other niches. The brand’s distribution footprint is larger than any DTC competitor: kits are stocked at Target, CVS, Walgreens, and other retail chains, making it the most-accessible entry point into at-home testing for buyers without an established online-buying habit.

In the 2026 DTC at-home-test landscape, Everlywell occupies a different category than the longevity-panel brands. It’s not competing on biomarker count or recommendation depth — it’s competing on breadth and accessibility. The trade-off is that the breadth has come with documented accuracy concerns on specific test types, and the per-kit pricing model can become expensive for users running multiple panels.

What We Measured

Note: This review is based on Everlywell’s published kit catalog, FDA enforcement actions and consumer-protection feedback documented through 2025–2026, and aggregated user reports. Hands-on testing of specific kits (collection experience, accuracy, results turnaround) is pending.

The 30+ kit catalog

Everlywell sells discrete kits across:

• Sexual health: STI panel, HPV (with documented accuracy concerns), syphilis, HIV
• Hormones: comprehensive female hormone, comprehensive male hormone, fertility panels
• Metabolic: HbA1c, lipid panel, comprehensive metabolic
• Thyroid: TSH, T3, T4, complete thyroid panel
• Vitamins: vitamin D, B12, folate, comprehensive micronutrient
• Food sensitivity: IgG-based panels (with significant editorial caveats — see below)
• Other: Lyme disease, COVID, women’s health, men’s health

This is the broadest DTC kit catalog in the consumer market. For users with a specific test need (e.g., “I want to check my testosterone before talking to a doctor”), Everlywell’s discrete-kit model can be more efficient than buying a comprehensive longevity panel from Function Health.

The accuracy concerns

The editorial gap with Everlywell is documented accuracy issues on specific test categories:

• HPV testing: FDA enforcement and consumer-protection scrutiny on accuracy (multiple instances 2020–2024). Cervical cancer screening should be done with a gynecologist using FDA-cleared clinical pathways, not at-home kits.
• Food sensitivity panels (IgG-based): Major medical organizations (American Academy of Allergy, Asthma & Immunology) explicitly state that IgG testing is not validated for food sensitivity diagnosis. Everlywell continues to market these panels; we recommend skipping them entirely.
• STI screening: Generally accepted as competent for screening (not diagnostic) purposes — false-negative rates are real, follow-up clinical testing is recommended for positive screens.
• Hormone and metabolic: Standard fingerprick or venous-draw accuracy via Everlywell’s CLIA-certified lab partners — competitive with category norms.

The pattern is kit-specific: not all Everlywell kits have accuracy concerns, but several high-profile categories do. Buyers should research the specific kit they’re considering against independent medical-organization positioning.

Subscription-charge complaints

Multiple consumer reports document unauthorized subscription charges after purchasing single-kit transactions. The pattern: a one-time kit purchase quietly enrolls the user in recurring shipments unless explicitly declined at checkout. BBB and consumer-protection complaints are documented through 2024–2026.

The editorial framing: Everlywell’s checkout flow has historically obscured the subscription opt-in. Buyers should carefully review checkout pages and monitor credit-card statements after Everlywell purchases.

3-Year Cost of Ownership

Use case	Annual cost	3-year total
Single-kit per year (e.g., comprehensive metabolic)	~$149	~$447
Quarterly testing (4 kits/year, mixed)	~$596	~$1,788
Frequent / multi-category testing	$1,000+	$3,000+

Compare: Function Health ($1,497 / 3 yr, 110+ measured biomarkers covered annually), SiPhox Health ($372–$735 / 3 yr depending on panel, designed for frequent testing), LetsGetChecked (similar discrete-kit model with vertically-integrated lab pricing).

For users running comprehensive longevity protocols, Function Health’s $499/yr for 110+ biomarkers is structurally better value than buying multiple Everlywell kits to cover similar biomarker breadth. For users with discrete one-off test needs, Everlywell’s per-kit pricing is reasonable.

Regulatory Status

Not FDA-Cleared as a service. Specific Everlywell kits run through CLIA-certified partner labs; some individual test panels have their own regulatory positioning (varies by category). The food-sensitivity IgG panels are particularly scrutinized — major medical organizations have publicly disputed the validity of this testing methodology.

For STI screening, all Everlywell tests are positioned as screening tools (not diagnostic), with recommendations for follow-up clinical testing on positive results.

When Everlywell Makes Sense — And When It Doesn’t

Strong fit:

• You have a specific discrete test need (single hormone panel, STI screen, vitamin levels) and want the most-accessible at-home option
• You value retail distribution — buying at Target/CVS rather than online
• You’re sophisticated enough to skip the IgG food-sensitivity panels and HPV-only kits
• You want a low-commitment entry point without subscription lock-in (with the caveat about checkout-flow subscription enrollment)

Weaker fit:

• You want comprehensive longevity-panel coverage — Function Health, Lifeforce, or InsideTracker are structurally better
• You value rapid turnaround — Everlywell’s 1–2 week results lag SiPhox’s 2–5 day turnaround
• You’re concerned about IgG food-sensitivity claims (you should be — these aren’t validated)
• You want clean subscription/billing UX — multiple complaints indicate Everlywell’s checkout flow is structurally problematic

Verdict: Conditional

Everlywell earns a conditional verdict on the strength of its category-leading kit catalog breadth and mass-market retail distribution — balanced against documented accuracy concerns on specific test types (HPV, IgG food sensitivity), unauthorized-subscription-charge complaints, and slower results turnaround than specialist competitors.

For specific discrete test needs (a one-off STI screen, a single vitamin panel, a hormone check before doctor visit), Everlywell’s accessibility and breadth make it a defensible choice. For comprehensive longevity-protocol bloodwork, Function Health is structurally better at scaled biomarker coverage; SiPhox is better at frequent-monitoring use cases.

The structural editorial concern: avoid the IgG food-sensitivity panels entirely — they’re not validated by major medical organizations and Everlywell continues to market them. This recommendation is independent of the broader brand verdict.

Changelog

• 2026-05-06: Initial review published based on Everlywell’s published kit catalog, FDA/consumer-protection enforcement actions, and aggregated user-report data. IgG food-sensitivity panel category flagged with a strong avoid recommendation.